StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
CLB$13.87+1.46%
Fair $13.87+0.0%

CLB

Core Laboratories Inc.

Energy / Oil & Gas Equipment & ServicesNYSE

$13.87

+0.20 (+1.46%)

Fairly Valued+0.0%Fair Value $13.87Fund rank 34/100 · Data gapFallback financials|
SA 41/C
F-Score: 7/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 24% · confianza 25%

FCF escenarios

weak_data · normalized FCF $22.3M · quality 68.0/100

Data gap 34/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 67/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

41/100

C

Piotroski

7/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

20/100

SEC 0%

Latest source: unknownPeriods: 5Warnings: 0unknown: 5
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists.
Thesis & Journal · CLBLocal privado en este navegador · Core Laboratories Inc.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$639M

P/E

22.7x

↑

EV/EBITDA

11.2x

↑

ROE

11.2%

↑

Gross Margin

17.9%

↓

Debt/Equity

0.62

↑
52-Week Range$14
$10$20

TradingView lightweight chart

CLB price, volumen y niveles de valoración

Último $13.87Periodo +44.1%
Fair value: $13.87

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2021–2025 · 4 años de histórico normalizado

Revenue CAGR

+2.9%

FCF CAGR

-0.8%

FCF margin

4.2%

FCF / Net income

0.75x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $526.5M · net income $29.7M · FCF $22.3M

2021-FY → 2025-FY

Gross margin

17.9%— pts

Operating margin

9.6%-0.0% pts

Net margin

5.6%+1.4% pts

FCF margin

4.2%-0.7% pts
MetricTTM
2025
2024
2023
2022
2021
Income Statement
Revenue$526.5M$526.5M$523.8M$509.8M$489.7M$470.3M
Net Income$29.7M$29.7M$31.4M$36.7M$19.5M$19.7M
EBITDA$71.1M$71.1M$73.5M$70.4M$58.7M$63.8M
EPS0.680.680.660.860.420.42
Gross Margin17.9%17.9%16.9%18.4%16.1%—
Operating Margin9.6%9.6%9.5%11.0%8.4%9.6%
Net Margin5.6%5.6%6.0%7.2%4.0%4.2%
Balance Sheet
Debt/Equity0.620.620.730.961.21—
Current Ratio2.052.05————
Cash Flow
Free Cash Flow$22.3M$22.3M$43.4M$14.2M$14.7M$23.0M
Returns
ROE11.2%11.2%12.7%16.3%10.6%—
Valuation
P/E22.7422.7428.4120.3450.39—
EV/EBITDA11.1611.1614.3514.6520.29—
P/B2.452.453.633.705.34—
Growth & Yield
Revenue Growth0.5%0.5%2.8%4.1%——
EPS Growth3.0%3.0%-23.3%106.2%——
Dividend Yield0.3%0.3%————

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

21.9%

exigente

EPS terminal req.

$1.23

Spread vs growth

-18.8%

5Y implied EPS CAGR

17.0%

exigente

EPS terminal req.

$1.49

Spread vs growth

-13.9%

10Y implied EPS CAGR

13.4%

razonable

EPS terminal req.

$2.40

Spread vs growth

-10.4%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +29.3%

Total return

+29.3%

Start / end P/E

16.3x → 20.4x

EPS bridge

0.66 → 0.68

Residual

+0.8%

EPS growth+3.0%
Multiple rerating+25.2%
Dividend+0.3%
Residual / FX / buybacks / cross-term+0.8%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.